REPORT ID 6808

Global Epigenetics Market Size, Status and Forecast 2022

Publish Date
1-Nov-17
Pages
102
Format
Electronic (PDF)

This report studies the global Epigenetics market, analyzes and researches the Epigenetics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Illumina Inc
    Merck & Co. Ltd.
    Qiagen
    Roche
    Eisai Co. Ltd.
    Novartis AG
    Abcam
    Diagenode
    Thermo Fisher Scientific
    Active Motif Inc.
    Zymo Research Corporation
    Cellcentric Limited
    Chroma Therapeutics
    Oncoloys Biopharma Inc.
    Syndex Pharmaceuticals
    Valirx Plc
    Sigma-Aldrich Corporation

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, Epigenetics can be split into
    DNA Methylation
    Histone Methylation
    Histone Acetylation
    Large Noncoding RNA
    MicroRNA Modification
    Chromatin Structures

Market segment by Application, Epigenetics can be split into
    Oncology
    Non-Oncology
    Solid Tumors
    Liquid Tumors
    Inflammatory Diseases
    Metabolic Diseases
    Infectious Diseases
    Cardiovascular Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Epigenetics Market Size, Status and Forecast 2022
1 Industry Overview of Epigenetics
    1.1  Epigenetics Market Overview
        1.1.1 Epigenetics Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Epigenetics Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Epigenetics Market by Type
        1.3.1 DNA Methylation
        1.3.2 Histone Methylation
        1.3.3 Histone Acetylation
        1.3.4 Large Noncoding RNA
        1.3.5 MicroRNA Modification
        1.3.6 Chromatin Structures
    1.4 Epigenetics Market by End Users/Application
        1.4.1 Oncology
        1.4.2 Non-Oncology
        1.4.3 Solid Tumors
        1.4.4 Liquid Tumors
        1.4.5 Inflammatory Diseases
        1.4.6 Metabolic Diseases
        1.4.7 Infectious Diseases
        1.4.8 Cardiovascular Diseases

2 Global Epigenetics Competition Analysis by Players
    2.1 Epigenetics Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Illumina Inc
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Epigenetics Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Merck & Co. Ltd.
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Epigenetics Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Qiagen
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Epigenetics Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Roche
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Epigenetics Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Eisai Co. Ltd.
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Epigenetics Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Novartis AG
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Epigenetics Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Abcam
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Epigenetics Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Diagenode
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Epigenetics Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Thermo Fisher Scientific
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Epigenetics Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Active Motif Inc.
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Epigenetics Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Zymo Research Corporation
    3.12 Cellcentric Limited
    3.13 Chroma Therapeutics
    3.14 Oncoloys Biopharma Inc.
    3.15 Syndex Pharmaceuticals
    3.16 Valirx Plc
    3.17 Sigma-Aldrich Corporation

4 Global Epigenetics Market Size by Type and Application (2012-2017)
    4.1 Global Epigenetics Market Size by Type (2012-2017)
    4.2 Global Epigenetics Market Size by Application (2012-2017)
    4.3 Potential Application of Epigenetics in Future
    4.4 Top Consumer/End Users of Epigenetics

5 United States Epigenetics Development Status and Outlook
    5.1 United States Epigenetics Market Size (2012-2017)
    5.2 United States Epigenetics Market Size and Market Share by Players (2016 and 2017)

6 EU Epigenetics Development Status and Outlook
    6.1 EU Epigenetics Market Size (2012-2017)
    6.2 EU Epigenetics Market Size and Market Share by Players (2016 and 2017)

7 Japan Epigenetics Development Status and Outlook
    7.1 Japan Epigenetics Market Size (2012-2017)
    7.2 Japan Epigenetics Market Size and Market Share by Players (2016 and 2017)

8 China Epigenetics Development Status and Outlook
    8.1 China Epigenetics Market Size (2012-2017)
    8.2 China Epigenetics Market Size and Market Share by Players (2016 and 2017)

9 India Epigenetics Development Status and Outlook
    9.1 India Epigenetics Market Size (2012-2017)
    9.2 India Epigenetics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Epigenetics Development Status and Outlook
    10.1 Southeast Asia Epigenetics Market Size (2012-2017)
    10.2 Southeast Asia Epigenetics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Epigenetics Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Epigenetics Revenue and Growth Rate (2017-2022)
        11.1.2 EU Epigenetics Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Epigenetics Revenue and Growth Rate (2017-2022)
        11.1.4 China Epigenetics Revenue and Growth Rate (2017-2022)
        11.1.5 India Epigenetics Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Epigenetics Revenue and Growth Rate (2017-2022)
    11.2 Global Epigenetics Market Size (Value) by Type (2017-2022)
    11.3 Global Epigenetics Market Size by Application (2017-2022)

12 Epigenetics Market Dynamics
    12.1 Epigenetics Market Opportunities
    12.2 Epigenetics Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Epigenetics Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Epigenetics Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source